Pharmacy

Your Article Summary

See Latest Articles

Medtronic Receives CE Mark for Second-Generation MRI Pacemaker
Medtronic, 06/22/09

Medtronic, Inc. announced it has received CE Mark for the company's second-generation pacemaker designed, tested, approved for use as labeled with MRI machines, the Advisa DR MRI SureScan pacing system. The Advisa MRI SureScan pacing system currently is not available for sale in the United States. Approximately 2 million Europeans have implanted pacemakers, but these patients are strongly discouraged from receiving MRI scans, a widely practiced diagnostic method for many common diseases and conditions, because their device could interact with MRI machines, potentially affecting the device or patient safety.

Today in Drug Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09

Sanofi Pasteur obtains license from Syntiron to develop & commercialize vaccine to prevent Staphylococcus infections
Sanofi-aventis, 12/17/09

Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09

 See all of Drug Approvals

Today in Drug/Product Alerts...keeping you current

Receive free subspecialty "5-minute updates" via email

Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09

 See all of Drug/Product Alerts